Complement Activation on B Lymphocytes Opsonized with Rituximab or Ofatumumab Produces Substantial Changes in Membrane Structure Preceding Cell Lysis.

Beum, P.V.; Lindorfer, M.A.; Beurskens, F.; Stukenberg, P.T.; Lokhorst, H.M.; Pawluczkowycz, A.W.; Parren, P.W.H.I.; van de Winkel, J.G.J.; Taylor, R.P.

Complement Activation on B Lymphocytes Opsonized with Rituximab or Ofatumumab Produces Substantial Changes in Membrane Structure Preceding Cell Lysis.

DSpace/Manakin Repository

Complement Activation on B Lymphocytes Opsonized with Rituximab or Ofatumumab Produces Substantial Changes in Membrane Structure Preceding Cell Lysis.

Beum, P.V.; Lindorfer, M.A.; Beurskens, F.; Stukenberg, P.T.; Lokhorst, H.M.; Pawluczkowycz, A.W.; Parren, P.W.H.I.; van de Winkel, J.G.J.; Taylor, R.P.

(2008) Journal of Immunology, volume 181, issue 1, pp. 822 - 832

(Article)

Download/Full Text

Open Access version via Utrecht University Repository

Unknown

ISSN: 0022-1767

Publisher: American Association of Immunologists

(Peer reviewed)

See more statistics about this item